Physician assessments of patient compliance with medical treatment

Goldberg, Albert I.; Cohen, Gilat; Rubin, Ami‐Hai E.

doi:10.1016/s0277-9536(98)00259-7

Cited by 37 publications

(18 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It has been reported that patients present higher adherence levels to treatments when the administration is simple and the recommendations are easy to understand, they are short-term treatments and the patients do not significantly alter their daily lives 7 . On the other hand, adherence studies through intravenous (IV) administration of MA would require hospitalization or a day-hospital base, a condition that we cannot afford for all CL patients in Rio de Janeiro.…”

Section: Discussionmentioning

confidence: 99%

Factors Associated to Adherence to Different Treatment Schemes With Meglumine Antimoniate in a Clinical Trial for Cutaneous Leishmaniasis

Ribeiro

Pimentel

Schubach

et al. 2014

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

The favorable outcome of the treatment of a disease is influenced by the adherence to therapy. Our objective was to assess factors associated with adherence to treatment of patients included in a clinical trial of equivalence between the standard and alternative treatment schemes with meglumine antimoniate (MA) in the treatment of cutaneous leishmaniasis (CL), in the state of Rio de Janeiro. Between 2008 and 2011, 57 patients with CL were interviewed using a questionnaire to collect socioeconomic data. The following methods were used for adherence monitoring: counting of vial surplus, monitoring card, Morisky test and modified Morisky test (without the question regarding the schedule); we observed 82.1% (vial return), 86.0% (monitoring card), 66.7% (Morisky test) and 86.0% (modified Morisky test) adherence. There was a strong correlation between the method of vial counting and the monitoring card and modified Morisky test. A significant association was observed between greater adherence to treatment and low dose of MA, as well as with a lower number of people sleeping in the same room. We recommend the use of the modified Morisky test to assess adherence to treatment of CL with MA, because it is a simple method and with a good performance, when compared to other methods.

show abstract

Section: Discussionmentioning

confidence: 99%

Factors Associated to Adherence to Different Treatment Schemes With Meglumine Antimoniate in a Clinical Trial for Cutaneous Leishmaniasis

Ribeiro

Pimentel

Schubach

et al. 2014

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

show abstract

“…The ratios alone could not be combined across participants due to different denominators; therefore, the ratios were divided and averaged to provide an overall study adherence value 3 . Analysis of prescription refills can provide crucial insights into patient willingness to comply and can be a valuable adjunct to decision making, in that physicians often have difficulty in appraising patient compliance [4][5][6] .…”

Section: Introductionmentioning

confidence: 99%

Pharmacy claims data as a tool to measure adherence

Leppée

Bošković

Čulig

et al. 2012

Current Medical Research and Opinion

View full text Add to dashboard Cite

Medication possession ratio (MPR) was introduced as a uniform methodology for estimating medication adherence from pharmacy claims data, but it does not provide accurate information on the continuity of medication usage and the measurement of medication persistency and identification of eventual gaps in medication supply. The combination of an MPR and a persistency metric could provide timely information on the dynamics of patient medication adherence.

show abstract

“…De acordo com proposta previamente publicada (GOLDBERG et al, 1998), foi feita pequena modificação no teste, de modo que cada resposta era seguida de pergunta relativa à freqüência. Porém, no presente estudo, avaliou-se a adesão por respostas dicotomizadas nos valores de 0 (zero) ou 1.…”

Section: Comportamento Não Intencionalunclassified

“…Mudanças de hábitos devidas ao uso do medicamento podem também influenciar negativamente a adesão. Outros aspectos que devem ser considerados, no estudo da adesão à terapêutica, estão presentes nos casos em que o tratamento afeta a relação com a atividade profissional, como medicamentos que causam sonolência em guardas-noturnos, ou em casos em que afetam a vida social, como a indicação da não-utilização de bebidas alcoólicas (GOLDBERG et al, 1998;LEITE et al, 2002;LEVY;FELD, 1999).…”

Section: Introductionunclassified

“…Como exemplo de motivos de não-adesão ao tratamento, ligados à própria terapêutica, é possível citar os casos de tratamentos longos e complexos, desconfortáveis, ou com prescrição de doses elevadas de um ou mais agentes medicamentosos (GIL et al, 1999;GOLDBERG et al, 1998;HAYNES, 1981B). Do mesmo modo, a não-adesão pode ser caracterizada pela tomada, por iniciativa do próprio paciente, de medicamentos não prescritos pelo médico (RAMALHINHO, 1994 GONÇALVES et al, 1999;LEITE et al, 2002).…”

Section: Introductionunclassified

See 1 more Smart Citation

"Investigação sobre a adesão ao tratamento medicamentoso em pacientes com doenças inflamatórias intestinais"

Dewulf¹

View full text Add to dashboard Cite

Physician assessments of patient compliance with medical treatment

Cited by 37 publications

References 17 publications

Factors Associated to Adherence to Different Treatment Schemes With Meglumine Antimoniate in a Clinical Trial for Cutaneous Leishmaniasis

Factors Associated to Adherence to Different Treatment Schemes With Meglumine Antimoniate in a Clinical Trial for Cutaneous Leishmaniasis

Pharmacy claims data as a tool to measure adherence

"Investigação sobre a adesão ao tratamento medicamentoso em pacientes com doenças inflamatórias intestinais"

Contact Info

Product

Resources

About